Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 5/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20124331 | 0.82 | ADORA1 (0.46) | ADORA1KDM4EALDH1A1L3MBTL1EGFR | |
| SCHEMBL20124327 | 0.78 | ADORA1 (0.47) | ADORA1KDM4EALDH1A1L3MBTL1EGFR | |
| SCHEMBL21913211 | 0.76 | KDM4E (0.37) | KDM4EALDH1A1L3MBTL1KMT2AMEN1 | |
| SCHEMBL21325673 | 0.73 | PDE2A (0.37) | KDM4EALDH1A1KMT2AMEN1MAPT | |
| SCHEMBL26453889 | 0.70 | EGFR (0.32) | ADORA1EGFR | |
| SCHEMBL19233749 | 0.69 | ADORA1 (0.51) | ADORA1KDM4EALDH1A1L3MBTL1EGFR | |
| SCHEMBL23343248 | 0.69 | GPR3 (0.42) | KDM4EALDH1A1L3MBTL1EGFRATM | |
| SCHEMBL25888956 | 0.69 | HSD17B10 (0.36) | KDM4EALDH1A1L3MBTL1KMT2AMEN1 | |
| SCHEMBL26455431 | 0.68 | ADORA1 (0.30) | ADORA1 | |
| SCHEMBL13317080 | 0.67 | ADORA1 (0.66) | ADORA1KDM4EALDH1A1L3MBTL1EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170362241-A1 | 1-FUNCTIONALIZED DIBENZOFURANS AND DIBENZOTHIOPHENES FOR ORGANIC LIGHT EMITTING DIODES (OLEDS) | IDEMITSU KOSAN CO., LTD. (JP) | 2017-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170362241-A1 | 1-FUNCTIONALIZED DIBENZOFURANS AND DIBENZOTHIOPHENES FOR ORGANIC LIGHT EMITTING DIODES (OLEDS) | OCIAD1, OCIAD2, DDT | ADORA1 2001/4885KDM4E 4056/4885ALDH1A1 99/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.